Human serum albumin nanoparticles loaded with phthalocyanine dyes for potential use in photodynamic therapy of atherosclerotic plaques
EntityUAM. Departamento de Química Orgánica
PublisherAndover House, Inc.
10.33218/prnano2(2).190411.1Precision Nanomedicine 2.2 (2019): 278-302
Funded byThe research leading to these results has received funding from FP7-NMP CosmoPHOS-Nano under grant agreement No. 310337. Additional funding was received by the Spanish groups from MINECO (CTQ2017-85393-P) and ERA-NET/MINECO EuroNanoMed2017-191 / PCIN-2017-042
Projectinfo:eu-repo/grantAgreement/EC/FP7/310337/EU//COSMOPHOS-NANO; Gobierno de España. CTQ2017-85393-P; Gobierno de España. PCIN-2017-042
SubjectsPhthalocyanine; Albumin Nanoparticles; Cardiovascular Disease; Photodynamic Therapy; Química
RightsAndover House, Andover, MA USA
Esta obra está bajo una licencia de Creative Commons Reconocimiento-NoComercial-SinObraDerivada 4.0 Internacional.
Diseases caused by obstruction or rupture of vulnerable plaques in the arterial walls such as cardiovascular infarction or stroke are the leading cause of death in the world. In the present work, we developed human serum albuminnanoparticles loaded by physisorption with zinc phthalocyanine, TT1, mainly used for industrial application as near-infrared photosensitizer and compared these to HSA NPsloaded with the well-known silicone phthalocyanine (Pc4). The use of NIR light allows for better tissue penetration, while the use of nanoparticles permitshigh local concentrations. The particles were characterized and tested for toxicity and stability as well as for their potential use as a contrast agent and NIR photosensitizer for photodynamic therapy in cardiovascular disease. We focused on the distribution of the nanoparticles in RAW264.7macrophage cells and atherosclerotic mice. The nanoparticles had an average size of 120 nm according todynamic light scattering, good loading capacity for zinc phthalocyanine,and satisfying stability in 50% (v/v) fetal bovine serum for 8 hours and in an aqueous environment at 4°C for 4–6 weeks. Under light irradiation we found a high production of singlet oxygen and the products showed no dark toxicity in vitro with macrophages(the target cells in vulnerable plaques),but at a low μg/mL nanoparticleconcentration killed efficiently the macrophagesupon LED illumination. Injection of the contrast agentin atherosclerotic mice led to a visible fluorescence signal of zinc phthalocyaninein the atherosclerotic plaque at 30 minutes and in the lungs with afast clearance of the nanoparticles. Zinc phthalocyanine loaded human serum albumin nanoparticles present an interesting candidate for the visualization and potentially photodynamictreatment of macrophages in atherosclerotic plaques
Google Scholar:Banerjee, Shubhadeep - Sengupta, Jayeeta - Aljarilla, Ana - Setaro, Francesca - Mäkinen, Petri I. - Wu, LinPing - Holappa, Lari - Escosura Navazo, Andrés de la - Martinelli, Chiara - Trohopoulos, Panagiotis N. - Ylä-Herttuala, Seppo - Urbanics, Rudolf - Szebeni, Janos - Torres Cebada, Tomás - Krol, Silke
This item appears in the following Collection(s)
Showing items related by title, author, creator and subject.